SEC Form 4 · accession 0001649101-26-000009
FLEX LTD. · FLEX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Revathi Advaithi
Officer — Chief Executive Officer · Director
Period of report
Jun 17, 2026
Accepted (ET)
Jun 22, 2026 · 8:52 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0000866374
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2 | Jun 17, 2026 | S | 1,301 | $141.7403 | D | 820,044 | D | |
| Ordinary SharesF3 | Jun 17, 2026 | S | 24,482 | $143.0313 | D | 795,562 | D | |
| Ordinary SharesF4 | Jun 17, 2026 | S | 19,078 | $143.9847 | D | 776,484 | D | |
| Ordinary SharesF5 | Jun 17, 2026 | S | 28,303 | $145.0605 | D | 748,181 | D | |
| Ordinary SharesF6 | Jun 17, 2026 | S | 8,178 | $145.8115 | D | 740,003 | D | |
| Ordinary SharesF7 | Jun 17, 2026 | S | 999 | $146.8907 | D | 739,004 | D | |
| Ordinary SharesF8 | Jun 17, 2026 | S | 175 | $147.656 | D | 738,829 | D | |
| Ordinary SharesF9 | Jun 17, 2026 | S | 984 | $149.1895 | D | 737,845 | D | |
| Ordinary SharesF2 | Jun 17, 2026 | S | 1,733 | $141.7364 | D | 736,112 | D | |
| Ordinary SharesF3 | Jun 17, 2026 | S | 33,387 | $143.0342 | D | 702,725 | D | |
| Ordinary SharesF4 | Jun 17, 2026 | S | 26,204 | $143.9849 | D | 676,521 | D | |
| Ordinary SharesF5 | Jun 17, 2026 | S | 38,857 | $145.0605 | D | 637,664 | D | |
| Ordinary SharesF6 | Jun 17, 2026 | S | 11,239 | $145.8109 | D | 626,425 | D | |
| Ordinary SharesF7 | Jun 17, 2026 | S | 1,374 | $146.8899 | D | 625,051 | D | |
| Ordinary SharesF8 | Jun 17, 2026 | S | 240 | $147.656 | D | 624,811 | D | |
| Ordinary SharesF9 | Jun 17, 2026 | S | 1,345 | $149.1896 | D | 623,466 | D | |
| Ordinary SharesF12 | Jun 18, 2026 | S | 16,282 | $144.8839 | D | 607,184 | D | |
| Ordinary SharesF13 | Jun 18, 2026 | S | 21,985 | $145.3487 | D | 585,199 | D | |
| Ordinary SharesF14,F15,F16 | Jun 18, 2026 | S | 921 | $146.3092 | D | 584,278 | D | |
| Ordinary SharesF17 | holding | — | — | — | 815,262 | I | By GRAT |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These sales as reported in this Form 4 were effected pursuant to a Rule 10b5-1(c) trading plan adopted by the Reporting Person on February 20, 2026.
- F10The sales reported in this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of performance-based restricted share units.
- F11The sales reported in this Form 4 represent shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted share units ("RSUs").
- F12Price reflects weighted average sales price; actual sales prices ranged from $144.08 to $145.075. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F13Price reflects weighted average sales price; actual sales prices ranged from $145.08 to $146.07. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F14Price reflects weighted average sales price; actual sales prices ranged from $146.12 to $146.56. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F15Includes the following: (1) 54,739 unvested RSUs, which will vest on June 12, 2027; and (2) 63,117 unvested RSUs, which will vest in two equal annual installments beginning on June 12, 2027.
- F16Each unvested RSU represents a contingent right to receive one unrestricted, fully transferable share for each vested RSU which has not been previously forfeited.
- F17Shares held by a grantor retained annuity trust ("GRAT") of which the reporting person is the trustee.
- F2Price reflects weighted average sales price; actual sales prices ranged from $141.49 to $142.46. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F3Price reflects weighted average sales price; actual sales prices ranged from $142.49 to $143.48. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F4Price reflects weighted average sales price; actual sales prices ranged from $143.49 to $144.48. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F5Price reflects weighted average sales price; actual sales prices ranged from $144.49 to $145.48. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F6Price reflects weighted average sales price; actual sales prices ranged from $145.49 to $146.48. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F7Price reflects weighted average sales price; actual sales prices ranged from $146.49 to $147.29. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F8Price reflects weighted average sales price; actual sales prices ranged from $147.58 to $147.69. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.
- F9Price reflects weighted average sales price; actual sales prices ranged from $149.15 to $149.50. The Reporting Person undertakes to provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.